glp 1 drugs and parkinson's disease A Big Week for GLP-1 - by Eric Topol How a 'blockbuster' treatment for
Description
Available from: Wang Y, Song X, Zhuang L, Lang H, Yu L, Yan X, et al
In the first trial, liraglutide lowered weight by 12 pounds and improved glucose tolerance relative to placebo over 4 months in 103 patients with schizophrenia spectrum disorders (Larsen JR et al, JAMA Psych 2017;74(1):719728)
Systolic (SBP) and diastolic blood pressure (DBP) can both be decreased by exercise alone by about 3.5 and 2.0mm Hg, respectively
Impact of High Glucose Levels and Glucose Lowering on Risk of Ischaemic Stroke: A Mendelian Randomisation Study and Meta-Analysis
